fda changes to tirzepatide The Impact of New Regulations on Tirzepatide for Weight Loss |

Cardiovascular outcome data for tirzepatide continues to accumulate through the SURMOUNT-MMO trial

GLP-1 injections increase insulin secretion in response to food intake and help the body use insulin more effectively

The MHRA and EMA include pancreatitis warnings in prescribing information, though current evidence suggests benefits generally outweigh risks in appropriately selected patients

Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP)

Is compounded semaglutide side effects different from brand-name Ozempic

Techniques that reduce stress, whether meditation, exercise, therapy, or simply protecting time for rest, support both conditions simultaneously